FDA.reportPublic FDA data

Muro 128

Manufacturer
Bausch & Lomb Incorporated
Effective date
2024-09-25
Label type
HUMAN OTC DRUG LABEL
Version
9
Source
full-release
Hydrated at
2026-06-01 00:22:06

Label at a glance#

ProductMuro 128
Active ingredientSODIUM CHLORIDE
Label structure10 sections

Indications and uses

temporary relief of corneal edema

Dosage and administration

pull down the lower lid of the affected eye apply a small amount (1/4 inch) of ointment to the inside of eyelid apply every 3 or 4 hours or as directed by a doctor

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Sodium chloride 5%

Purpose

OTC - PURPOSE SECTION

Hypertonicity agent

Uses

INDICATIONS & USAGE SECTION

temporary relief of corneal edema

Warnings

WARNINGS SECTION

For external use only

Do not use
except under the advice and supervision of a doctor.

When using this product 

  • it may cause temporary burning and irritation
  • replace cap after use
  • to avoid contamination, do not touch tip of container to any surface

Stop use and ask a doctor if

  • condition worsens or persists for more than 72 hours
  • you experience eye pain, changes in vision, continued redness or irritation of the eye

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • pull down the lower lid of the affected eye
  • apply a small amount (1/4 inch) of ointment to the inside of eyelid
  • apply every 3 or 4 hours or as directed by a doctor

Other information

SPL UNCLASSIFIED SECTION

  • store at 15-25 °C (59-77 °F)
  • keep tightly closed
  • DO NOT FREEZE
  • see crimp of tube or carton for Lot Number and Expiration Date
  • do not use if difficult to dispense or visible particles are seen in the product
  • serious side effects associated with use of the product may be reported to the phone number provided below 

Inactive ingredients

INACTIVE INGREDIENT SECTION

lanolin, mineral oil, purified water, white petrolatum

Questions or comments?

OTC - QUESTIONS SECTION

Call1-800-553-5340

Package/Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

cartoncartonBAUSCH +LOMB

NDC 24208-385-56

Muro 128 ®

sodium chloride hypertonicity

ophthalmic ointment, 5%

OINTMENT

5%|

Temporary Relief

of Corneal Edema

TWIN

PACK

STERILE

NET WT. 1/4 OZ. (7 g)

TWO 1/8 OZ (3.5 g) Tubes

9758101
AB15899

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1299626Muro 128 5 % Ophthalmic OintmentPSN9
1298435sodium chloride 5 % Ophthalmic OintmentPSN9
1299626sodium chloride 0.000855 MEQ/MG Ophthalmic Ointment [Muro 128]SBD9
1298435sodium chloride 0.000855 MEQ/MG Ophthalmic OintmentSCD9
1299626Muro 128 0.000855 MEQ/MG Ophthalmic OintmentSY9
1299626Muro 128 5 % Ophthalmic OintmentSY9
1298435NaCl 0.000855 MEQ/MG Ophthalmic OintmentSY9
1299626NaCl 0.000855 MEQ/MG Ophthalmic Ointment [Muro 128]SY9
1298435NaCl 5 % Ophthalmic OintmentSY9
1298435sodium chloride 50 MG (5 % ) Ophthalmic OintmentSY9

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
SODIUM CATION Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
95250459-30e4-45c1-b08a-993044f49109Product name220250805
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
24208-385-01Muro 1281 in 1 CARTONOINTMENT19
24208-385-01Muro 1281 g in 1 TUBEOINTMENT19
24208-385-55Muro 1283.5 g in 1 TUBEOINTMENT3.59
24208-385-55Muro 1281 in 1 CARTONOINTMENT19
24208-385-56Muro 1282 in 1 CARTONOINTMENT29
24208-385-56Muro 1283.5 g in 1 TUBEOINTMENT3.59

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
24208-385MURO 128 (SODIUM CHLORIDE) OINTMENT [BAUSCH & LOMB INCORPORATED]9Current NDC, Legacy NDC, 6 package rows20240927_93fafa27-5031-4d95-b4b8-5574b7204ae2.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24208-385-55GM - Gram24208-3851f043133-647b-4b55-8dcc-c53718560d2912012-07-24
24208-385-56GM - Gram24208-38512e8441e-0ecf-4788-92d2-2985284488e712014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
SODIUM CHLORIDEACTIVE INGREDIENT451W47IQ8X4
SODIUM CATIONACTIVE MOIETYLYR4M0NH374
LANOLININACTIVE INGREDIENT7EV65EAW6H4
MINERAL OILINACTIVE INGREDIENTT5L8T28FGP4
PETROLATUMINACTIVE INGREDIENT4T6H12BN9U4
WATERINACTIVE INGREDIENT059QF0KO0R4

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
24208-38524208-385-55, 24208-385-56, 24208-385-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
LANOLIN7EV65EAW6HIACT
WATER059QF0KO0RIACT
PETROLATUM4T6H12BN9UIACT
MINERAL OILT5L8T28FGPIACT
SODIUM CHLORIDE451W47IQ8XACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 12 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
LANOLINLANOLIN7EV65EAW6HOINTMENT / OPHTHALMIC3 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
LANOLINLANOLIN7EV65EAW6HOINTMENT / OPHTHALMIC3 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
LANOLINLANOLIN7EV65EAW6HOINTMENT / OPHTHALMIC3 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / OPHTHALMIC88.4 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / OPHTHALMIC88.4 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / OPHTHALMIC88.4 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
LANOLINLANOLIN7EV65EAW6HOINTMENT / OPHTHALMIC3 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / OPHTHALMIC59.5 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / OPHTHALMIC59.5 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PETROLATUMPETROLATUM4T6H12BN9UOINTMENT / OPHTHALMIC88.4 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / OPHTHALMIC59.5 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / OPHTHALMIC59.5 %w/wExact identifier — unii+route+dosage form
4 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Muro 128SODIUM CHLORIDEBausch & Lomb Incorporated93fafa27-5031-4d95-b4b8-5574b7204ae22024-09-25WarningsExact identifier
ndc (package): 24208-385-56
ndc (package): 24208-385-55
ndc (package): 24208-385-01
ndc (product): 24208-385
ndc11 (package): 24208038556
ndc11 (package): 24208038555
ndc11 (package): 24208038501
spl id: 22f5a4ba-407c-faf9-e063-6394a90a17a5
spl set id: 93fafa27-5031-4d95-b4b8-5574b7204ae2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.